Since loss of BRCA1 protein expression has also been reported in sporadic breast cancer patients despite having intact BRCA1 gene [13, 15], testing for an additional biomarker indicative of the presence of BRCA1, such as Rak, would provide a more precise representation of tumor characteristics and a complementary strategy, thereby improving patient outcomes. Here, BRCA1 is linked to breast carcinoma.